Clinical Trials List
Protocol NumberU31402-A-U201
Active
2020-09-15 - 2025-10-08
Phase II
Terminated2
ICD-10C33
Malignant neoplasm of trachea
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.0
Malignant neoplasm of trachea
-
Trial Applicant
Syneos Health
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- Chih-Liang Wang Division of Thoracic Medicine
- 林定佑 Division of Thoracic Medicine
- Wen-Cheng Chang Division of Thoracic Medicine
- Shih-Hong Li Division of Thoracic Medicine
- 柯皓文 Division of Thoracic Medicine
- Chih-Hung Chen Division of Thoracic Medicine
- 吳教恩 Division of Hematology & Oncology
- 邱立忠 Division of Thoracic Medicine
- 張境夫 Division of Thoracic Medicine
- 枋岳甫 Division of Thoracic Medicine
- Ping-Chih Hsu Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- CHAO-CHI HO CHAO-CHI HO Division of General Internal Medicine
- YEN-TING LIN Division of General Internal Medicine
- 徐偉勛 Division of Hematology & Oncology
- 楊景堯 Division of General Internal Medicine
- 吳尚俊 Division of General Internal Medicine
- Chia-Chi Lin Division of Hematology & Oncology
- 陳冠宇 Division of General Internal Medicine
- 廖斌志 Division of Hematology & Oncology
- Chong-Jen Yu Division of General Internal Medicine
- 林昭文 Division of General Internal Medicine
- 許嘉林 Division of General Internal Medicine
- 廖唯昱 Division of General Internal Medicine
- Jih-Hsiang Lee Division of Hematology & Oncology
- JIN-YUAN SHIH Division of General Internal Medicine
- 蔡子修 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
300 participants
